MCO
80
2
COST
56
3
MMM
52
2
PDCO
54
-4
HAS
55
-2
VRSN
53
-2
NEM
48
2
GPC
37
-14
BBY
56
-2
AEP
58
2
BF.B
43
-7
PCAR
50
-3
EQR
54
-2
O
31
3
PCG
80
3
MAS
67
-3
NTAP
60
2
L
55
-4
NRG
69
12
CFG
38
-2
MCO
80
2
COST
56
3
MMM
52
2
PDCO
54
-4
HAS
55
-2
VRSN
53
-2
NEM
48
2
GPC
37
-14
BBY
56
-2
AEP
58
2
BF.B
43
-7
PCAR
50
-3
EQR
54
-2
O
31
3
PCG
80
3
MAS
67
-3
NTAP
60
2
L
55
-4
NRG
69
12
CFG
38
-2
Financhill
Back

Marriott International Vs. Apellis Pharmaceuticals Industry Stock Comparison

Buy
60

MAR
Marriott International

Last Price:
244.37
Seasonality Move:
4.66%
Sell
19

APLS
Apellis Pharmaceuticals

Last Price:
32.49
Seasonality Move:
18.8%
Buy
60
Marriott International (MAR) is a Buy

Is Marriott International a Buy, Sell or Hold?

  • The current Marriott International [MAR] share price is $244.39. The Score for MAR is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
  • MAR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
19
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $32.50. The Score for APLS is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

MAR Stock Price Chart

What is Marriott International's stock price today?

  • The Marriott International share price today is $244.39
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MAR is experiencing buying pressure, which is a positive indicator for future bullish movement.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $32.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight selling pressure.

MAR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 3.54 Buy
Relative Strength Index (14 RSI): 71.39 Buy
Chaikin Money Flow: 2945026 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (223.87 - 235.73) Buy
Bollinger Bands (100): (224.85 - 242.45) Buy

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.84 Sell
Relative Strength Index (14 RSI): 33.6 Sell
Chaikin Money Flow: -1084788 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (36.37 - 40.01) Sell
Bollinger Bands (100): (36.55 - 42.35) Sell

MAR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 235.68 Buy
20-day SMA: 231.38 Buy
50-day SMA: 229.96 Buy
200-day SMA: 236.16 Buy
8-day EMA: 237.43 Buy
20-day EMA: 232.59 Buy
50-day EMA: 231.3 Buy
200-day EMA: 228.64 Buy

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.19 Sell
20-day SMA: 38.04 Sell
50-day SMA: 37.88 Sell
200-day SMA: 50 Sell
8-day EMA: 35.96 Sell
20-day EMA: 37.21 Sell
50-day EMA: 38.25 Sell
200-day EMA: 45.7 Sell

Marriott International Earnings Growth & MAR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.20 per share, an increase next quarter of $0.49 per share, an increase this year of $0.78 per share, and an increase next year of $1.25 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.74 per share, an increase next quarter of $0.23 per share, an increase this year of $3.28 per share, and an increase next year of $1.34 per share.

Marriott International Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):